Making Gender: Big Pharma, HPV Vaccine Policy, and Women’s Ontological Decision-Making
Available: October 2023© 2023
Imprint: University of Toronto Press
Page Count: 200 Pages
Illustrations: 3 b&w figures, 3 b&w tables
Dimensions: 6.00 x 9.00
200 Pages, 6.00 x 9.00 x 1.00 in, 3 b&w figures, 3 b&w tables
Not Yet Published
Making Gender endeavours to understand how the HPV vaccine became gendered within the Canadian policy landscape – when the virus is gender blind and is linked to cancer in all genders – and how women’s experiences with this "gendered risk" have been folded into their vaccine decision-making.
Drawing on ethnographic fieldwork and archival research, Michelle Wyndham-West explores the creation and circulation of gendered risk as it was deployed in pharmaceutical and policy discourses surrounding the rollout of the HPV vaccine. The book contextualizes the background for how gendered risk was mediated by two groups of women: mothers negotiating the vaccine for their daughters in school-based immunization programs and university students who experienced frequent HPV infections. The book explores these women’s efforts to be good mothers and strong young women entering adulthood who felt vulnerable in sexual health negotiation. As a result, Making Gender reveals how vaccine decision-making took an ontological form, as an inherently social and cultural process embedded in women’s experiences.
2. Navigating Controversies and Doing Mothering: Making HPV Vaccine Decisions for Their Daughters
3. University-Aged Women’s Experiences with HPV Infection and Vaccine Decision-Making
4. Media Landscape: Controversies and Competing Narratives
5. Vaccine Marketing by Harnessing Hegemonic Cultural Discourses of Risk and Gender
6. Gendered Vaccine Policymaking
7. Conclusion: Theoretical Contributions and Reassessing Gender-Based Analysis Policymaking